Morgan Stanley
GPAT

Morgan Stanley’s GP-Act III Acquisition Corp GPAT Stock Holding History

Morgan Stanley’s Portfolio GPAT Stock Details GPAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$694 Sell
64
-15
-19% -$161 ﹤0.01% 7540
2025
Q4 		$845 Buy
79
+23
+41% +$245 ﹤0.01% 7406
2025
Q3 		$594 Sell
56
-79
-59% -$835 ﹤0.01% 7468
2025
Q2 		$1.42K Buy
135
+103
+322% +$1.08K ﹤0.01% 7290
2025
Q1 		$329 Buy
+32
New +$328 ﹤0.01% 7420

Other funds holding GPAT

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return

Morgan Stanley's GPAT Position: Q1 2026 in Review

Morgan Stanley reduced its GP-Act III Acquisition Corp (GPAT) stake by 19% in Q1 2026, selling an estimated $161 and leaving 64 shares worth $694. The position accounts for ﹤0.01% of the portfolio, ranked #7540.

Morgan Stanley first reported a position in GPAT in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.42K in Q2 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Morgan Stanley held 64 shares of GP-Act III Acquisition Corp worth $694 as of Q1 2026.
  • Morgan Stanley sold 15 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $161.
  • GP-Act III Acquisition Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7540 holding.
  • Morgan Stanley first reported a position in GP-Act III Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Morgan Stanley's GP-Act III Acquisition Corp position peaked at $1.42K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.